Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.3
Impact Factor 2024
1.5
CiteScore 2024
1.3
Impact Factor 2024
1.5
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Real-world treatment patterns, patient-reported outcomes, and effectiveness of flexible-dosing etanercept in patients with plaque psoriasis in Greece

    Dimitris Rigopoulos, Aikaterini Patsatsi, Christina Antoniou, Dimitrios Sotiriadis, Angeliki Roussaki-Schulze, Nadia Boubouchairopoulou, Ioannis Skiadas, Vasillios Tsekouras, Ana Cristina Hernandez Daly
    21-11-2022
    https://doi.org/10.4081/dr.2022.9265
    1531
    PDF: 450
    HTML: 27
  • Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

    Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone
    29-07-2021
    https://doi.org/10.4081/dr.2021.8797
    3060
    PDF: 647
    HTML: 10
  • Treatment modalities of necrobiosis lipoidica: a concise systematic review

    Amir Feily, Shadi Mehraban
    08-06-2015
    https://doi.org/10.4081/dr.2015.5749
    2890
    PDF: 1897
    Suppl. Table: 441
    HTML: 493
  • Dimethyl fumarate as a safe and effective therapy for recalcitrant psoriasis in comorbid patients

    Martina Burlando, Mattia Fabio Molle, Emanuele Cozzani, Aurora Parodi
    14-03-2022
    https://doi.org/10.4081/dr.2022.9091
    2625
    PDF: 632
    HTML: 6
  • Combination of cyclosporine A and methylprednisolone to treat pediatric Stevens-Johnson syndrome/toxic epidermal necrolysis overlap syndrome

    Shinta Trilaksmi Dewi, Laily Noor Qomariah, Widya Khairunisa Sarkowi, Monika Puspitasari, Miya Khalidah, Marcella Anggatama, Dwinanda Almira Rizkiani, Kristiana Etnawati, Sri Awalia Febriana
    19-06-2023
    https://doi.org/10.4081/dr.2023.9656
    1279
    PDF: 634
    HTML: 183
  • A microRNA focus on acne

    Sarah Gordon, Alison M. Layton, Sandra Fawcett, Kehinde Ross
    02-02-2024
    https://doi.org/10.4081/dr.2024.9902
    1081
    PDF: 717
    HTML: 57
  • Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

    Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
    11-10-2017
    https://doi.org/10.4081/dr.2017.7079
    1377
    PDF: 662
    HTML: 142
  • Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

    Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
    17-03-2022
    https://doi.org/10.4081/dr.2022.9282
    1162
    PDF: 825
    HTML: 41
  • Certolizumab to treat hidradenitis suppurativa

    Asem Shadid, Saud Alobaida, Yousef Binamer
    27-10-2022
    https://doi.org/10.4081/dr.2022.9566
    1939
    PDF: 728
    HTML: 28
  • Severe relapse of generalized psoriasis in a young patient with a Löfgren syndrome history

    Ermira Ziçishti, Migena Vargu, Sabina Dedej, Eriselda Kurushi, Valbona Zenelaj, Ermira Vasili
    13-03-2025
    https://doi.org/10.4081/dr.2025.10021
    442
    PDF: 305
    HTML: 7
  • Exacerbation of generalized plaque psoriasis after tuberculin test

    Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Walter Volpi, Marzia Caproni
    28-07-2021
    https://doi.org/10.4081/dr.2021.9019
    3189
    PDF: 503
    HTML: 227
  • Treatment satisfaction among patients with psoriasis in Saudi Arabia

    Mahdi Aldhafiri, Rahaf Almutairi, Reem Albejais, Asma Almubark, Hussain Alwesaibie, Mohammed Albesher, Manayer Almustihi
    15-04-2024
    https://doi.org/10.4081/dr.2024.9967
    1039
    PDF: 553
    HTML: 29
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

    Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino
    25-06-2020
    https://doi.org/10.4081/dr.2020.8642
    1352
    PDF: 751
    HTML: 8
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1306
    PDF: 405
    HTML: 45
  • Pemphigus vulgaris mimicking Steven-Johnson syndrome/toxic epidermal necrolysis: report of an unusual case

    Latifah Albrahim, Amal Aboud Alasmari, Majed Aleissa
    23-05-2023
    https://doi.org/10.4081/dr.2023.9649
    1824
    PDF: 503
    HTML: 21
  • Erythrodermic psoriasis treated with apremilast

    John Arcilla, Daniel Joe, Johnathan Kim, Yohanan Kim, VuAnh N. Truong, Navin Jaipaul
    19-09-2016
    https://doi.org/10.4081/dr.2016.6599
    2122
    PDF: 964
    HTML: 600
  • The first reported case of erythrodermic sarcoidosis with systemic involvement during COVID-19 vaccination

    Georgi Tchernev, Simona Kordeva, Heily Kirilova, Valentina Broshtilova
    01-03-2023
    https://doi.org/10.4081/dr.2023.9636
    1215
    PDF: 592
    HTML: 68
  • Efficacy of tildrakizumab 200 mg for treating difficult-to-treat patient populations with moderate-to-severe plaque psoriasis

    Paolo Dapavo, Matteo Megna, Marina Talamonti
    09-08-2024
    https://doi.org/10.4081/dr.2024.9999
    1739
    PDF: 669
    HTML: 94
  • Mortality risk factors in febrile ulceronecrotic Mucha- Habermann disease: a systematic review of therapeutic outcomes and complications

    Vasiliki Tasouli-Drakou, May Nguyen, Hannah Guinn, Omron Hassan, Sneha Butala, Sheshanna Phan
    21-11-2022
    https://doi.org/10.4081/dr.2022.9492
    1686
    PDF: 679
    HTML: 85
1 - 19 of 19 items

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy